Rationale for and design of the TRUE-AHF trial: the effects of ularitide on the short-term clinical course and long-term mortality of patients with acute heart failure-Reference-Cited by-同舟云学术

Rationale for and design of the TRUE-AHF trial: the effects of ularitide on the short-term clinical course and long-term mortality of patients with acute heart failure

Published:2016-11-13 Issue:5 Volume:19 Page:673-681
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Packer Milton¹,Holcomb Richard²,Abraham William T.³,Anker Stefan⁴,Dickstein Kenneth⁵,Filippatos Gerasimos⁶,Krum Henry⁷,Maggioni Aldo P.⁸,McMurray John J.V.⁹,Mebazaa Alexandre¹⁰,O'Connor Christopher¹¹,Peacock Frank¹²,Ponikowski Piotr¹³,Ruschitzka Frank¹⁴,van Veldhuisen Dirk J.¹⁵,Holzmeister Johannes¹⁴¹⁶,

Affiliation:

1. Baylor Heart and Vascular Institute; Baylor University Medical Center; Dallas TX USA

2. Study Biostatistician Wayzata; MN USA

3. Ohio State University Heart and Vascular Center; Columbus OH USA

4. Innovative Clinical Trials, Department of Cardiology & Pneumology; University Medical Center Göttingen (UMG); Göttingen Germany

5. Division of Cardiology; University of Bergen; Stavanger Norway

6. National and Kapodistrian University of Athens, School of Medicine; Attikon Athens University Hospital, Department of Cardiology; Athens Greece

7. Monash University; Centre of Cardiovascular Research & Education in Therapeutics; Melbourne Australia

8. Centro Studi ANMCO; Fondazione ‘per il Tuo cuore’ HCF ONLUS; Firenze Italy

9. Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre; University of Glasgow; Glasgow UK

10. University of Paris, Department of Anesthesia and Critical Care; Hôpitaux Universitaire Saint Louis Lariboisière; Paris France

11. Inova Heart and Vascular Institute; Falls Church VA USA

12. Baylor College of Medicine; Houston TX USA

13. Poland Wroclaw Medical University; Wroclaw Poland

14. Cardiology; University Hospital Zurich; Zurich Switzerland

15. University Medical Center Groningen; Groningen The Netherlands

16. Cardiorentis AG; Zug Switzerland

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference50 articles.

1. Natriuretic peptides in cardiovascular diseases: current use and perspectives;Volpe;Eur Heart J,2014

2. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions;Potter;Endocr Rev,2006

3. Molecular physiology of natriuretic peptide signalling;Kuhn;Basic Res Cardiol,2004

4. Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects;Brunner-La Rocca;J Am Coll Cardiol,2001

5. C-type natriuretic peptide: the endothelial component of the natriuretic peptide system;Chen;J Cardiovasc Pharmacol,1998

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natriuretic Peptide Receptors (NPRs) as a Potential Target for the Treatment of Heart Failure;Current Heart Failure Reports;2023-09-15

2. Peptide mediated therapy in fibrosis: Mechanisms, advances and prospects;Biomedicine & Pharmacotherapy;2023-01

3. Atrial fibrillation associated with heart failure treated by a 2-lead CRT-DX system (BIO-AffectDX): Study design and clinical protocol;Heart Rhythm O2;2021-12

4. Recent and Upcoming Drug Therapies for Pediatric Heart Failure;Frontiers in Pediatrics;2021-11-11

5. Current and Future Drug and Device Therapies for Pediatric Heart Failure Patients: Potential Lessons from Adult Trials;Children;2021-04-22